Current Edition

Clinical Trials in Russia – Report on Q3 of 2013

The Ministry of Health of the Russian Federation approved 200 new clinical trials of all types during the 3rd quarter of 2013. The main contribution to the total number of studies was made by multinational multi-centre clinical trials (MMCT). The number of bioequivalence studies decreased from 64 studies in Q3 2012 to 51 in Q3 2013, while the number of local clinical trials decreased from 53 to 47 clinical trials. Igor Stevanov of Synrg Research Group summarises developments in the Russian clinical trials market in 2013.